Stryker Corp. (SYK)
294.66
+1.43
(+0.49%)
USD |
NYSE |
Oct 16, 16:00
294.68
+0.02
(+0.01%)
After-Hours: 20:00
Stryker Cash from Investing (Quarterly) : -639.00M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -639.00M |
| March 31, 2026 | -185.00M |
| December 31, 2025 | -305.00M |
| September 30, 2025 | -321.00M |
| June 30, 2025 | -104.00M |
| March 31, 2025 | -4.136B |
| December 31, 2024 | -303.00M |
| September 30, 2024 | -2.172B |
| June 30, 2024 | -117.00M |
| March 31, 2024 | -408.00M |
| December 31, 2023 | -152.00M |
| September 30, 2023 | -145.00M |
| June 30, 2023 | -533.00M |
| March 31, 2023 | -132.00M |
| December 31, 2022 | -162.00M |
| September 30, 2022 | 72.00M |
| June 30, 2022 | -152.00M |
| March 31, 2022 | -2.682B |
| December 31, 2021 | -314.00M |
| September 30, 2021 | -247.00M |
| June 30, 2021 | -202.00M |
| March 31, 2021 | -96.00M |
| December 31, 2020 | -4.352B |
| September 30, 2020 | -69.00M |
| June 30, 2020 | -117.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -163.00M |
| December 31, 2019 | -719.00M |
| September 30, 2019 | -186.00M |
| June 30, 2019 | -247.00M |
| March 31, 2019 | -303.00M |
| December 31, 2018 | -1.628B |
| September 30, 2018 | -156.00M |
| June 30, 2018 | -233.00M |
| March 31, 2018 | -854.00M |
| December 31, 2017 | -559.00M |
| September 30, 2017 | -815.00M |
| June 30, 2017 | -192.00M |
| March 31, 2017 | -146.00M |
| December 31, 2016 | -177.00M |
| September 30, 2016 | -102.00M |
| June 30, 2016 | -3.969B |
| March 31, 2016 | 57.00M |
| December 31, 2015 | -585.00M |
| September 30, 2015 | 315.00M |
| June 30, 2015 | 1.90B |
| March 31, 2015 | 326.00M |
| December 31, 2014 | -88.00M |
| September 30, 2014 | -424.00M |
| June 30, 2014 | -1.015B |
| March 31, 2014 | -351.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | -26.60M |
| Zimmer Biomet Holdings, Inc. | -190.80M |
| Abbott Laboratories | -673.00M |
| Becton, Dickinson & Co. | -228.00M |
| Boston Scientific Corp. | -1.956B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.261B |
| Cash from Financing (Quarterly) | -95.00M |
| Free Cash Flow | 4.702B |
| Free Cash Flow Per Share (Quarterly) | 2.744 |
| Free Cash Flow to Equity (Quarterly) | 847.00M |
| Free Cash Flow to Firm (Quarterly) | 1.174B |
| Free Cash Flow Yield | 4.13% |